VIRX - Viracta gets orphan drug status for Nana-val for EBV tumors
2023-12-12 11:14:57 ET
More on Viracta Therapeutics
- Viracta Therapeutics GAAP EPS of -$0.33 misses by $0.03
- Seeking Alpha’s Quant Rating on Viracta Therapeutics
- Historical earnings data for Viracta Therapeutics
- Financial information for Viracta Therapeutics
For further details see:
Viracta gets orphan drug status for Nana-val for EBV tumors